Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/15103
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Ginderachter, Laura-
dc.contributor.authorCox, Tony-
dc.contributor.authorDrijkoningen, Ria-
dc.contributor.authorACHTEN, Ruth-
dc.contributor.authorJoosens, Eric-
dc.contributor.authorMaes, Annelies-
dc.contributor.authorTheunissen, Koen-
dc.contributor.authorMEBIS, Jeroen-
dc.date.accessioned2013-04-24T12:21:28Z-
dc.date.available2013-04-24T12:21:28Z-
dc.date.issued2013-
dc.identifier.citationCase Report Oncology, 6, p. 45-49-
dc.identifier.issn1662-6575-
dc.identifier.urihttp://hdl.handle.net/1942/15103-
dc.description.abstractTemozolomide (TMZ) is an alkylating agent, used for the treatment of high-grade gliomas. This case report describes the development of a non-Hodgkin lymphoma in a patient treated with extended-dose temozolomide and radiotherapy. In addition to the possible mutagenic effect of temozolomide – as described for all alkylating agents – there might have been an immunosuppressive effect of TMZ. The pathological appearance of the lymphoma as well as the presence of a grade 3 lymphopenia early in treatment supports this hypothesis. As the use of TMZ increases, the awareness that TMZ may induce secondary malignancies should increase as well.-
dc.language.isoen-
dc.titleNon-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case report-
dc.typeJournal Contribution-
dc.identifier.epage49-
dc.identifier.spage45-
dc.identifier.volume6-
local.bibliographicCitation.jcatA2-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1159/000346614-
item.fulltextNo Fulltext-
item.contributorMEBIS, Jeroen-
item.contributorJoosens, Eric-
item.contributorTheunissen, Koen-
item.contributorACHTEN, Ruth-
item.contributorCox, Tony-
item.contributorMaes, Annelies-
item.contributorVan Ginderachter, Laura-
item.contributorDrijkoningen, Ria-
item.fullcitationVan Ginderachter, Laura; Cox, Tony; Drijkoningen, Ria; ACHTEN, Ruth; Joosens, Eric; Maes, Annelies; Theunissen, Koen & MEBIS, Jeroen (2013) Non-Hodgkin Lymphoma after treatment with Extended dosing temozolomide and radiotherapy for a glioblastoma: A case report. In: Case Report Oncology, 6, p. 45-49.-
item.accessRightsClosed Access-
crisitem.journal.issn1662-6575-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

1
checked on Sep 7, 2020

Page view(s)

60
checked on Jun 14, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.